Sharon Cunningham is the founder of Shorla Pharma. Shorla Pharma has raised $35M in total funding. Latest round: Series B. Based in Cambridge, USA.
Sharon Cunningham is the chief executive officer and co-founder of Shorla Pharma, a U.S.-Ireland specialty pharmaceutical company established in 2018. The company focuses on developing oncology treatments, particularly for orphan and pediatric cancers. Shorla Pharma recently secured $35 million in Series B funding to further its oncology initiatives.
Full founder directory · Investor directory · Company funding database · Fundraising library